$INCY · INCYTE CORP SEC Filings
Position Tracker tracks 2 SEC EDGAR filings for INCYTE CORP ($INCY) from October 29, 2026 through October 29, 2026, including 0 Form 10-K annual reports, 1 Form 10-Q quarterly earnings reports, 1 Form 8-K current event disclosures, and 0 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.
$INCY 10-Q — INCYTE CORP
A profitable biotech swinging to a $784.8M quarterly loss on a 3.5x R&D surge is a dramatic capital-allocation signal that demands investor scrutiny of the pipeline return prosp…
$INCY 8-K — INCYTE CORP
The Vega charge masks accelerating commercial execution — core ex-Jakafi products grew 36-38% — while four pivotal Phase 3 readouts and a potential EU povorcitinib approval land…